Looking for Sense in the Italian Antitrust Authority Decision in the Pfizer Xalatan Case
Antitrust Chronicle, 2012, vol. 7
The IAA could find for the existence of the abuse only by misconstruing the very essence of patent law. Daniela Ampollini (Trevisan & Cuonzo)
JEL-codes: G38 (search for similar items in EconPapers)
References: Add references at CitEc
Citations Track citations by RSS feed
Downloads: (external link)
http://www.competitionpolicyinternational.com/look ... -pfizer-xalatan-case (application/pdf)
Requires login and subscription
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: http://EconPapers.repec.org/RePEc:cpi:atchrn:7.2.2012:i=7742
Access Statistics for this article
More articles in Antitrust Chronicle from Competition Policy International
Series data maintained by Lindsay McSweeney ().